Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 200
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Solanbridge Group, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or assets. The company was formerly known as Solanex Management, Inc. and changed its name to Solanbridge Group, Inc. in January 2011. Solanbridge Group, Inc. was incorporated...
Show more
Solanbridge Group, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or assets. The company was formerly known as Solanex Management, Inc. and changed its name to Solanbridge Group, Inc. in January 2011. Solanbridge Group, Inc. was incorporated in 2000 and is headquartered in Lakewood, Colorado.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 720 442 9960
- Address
- PO Box 147199, Lakewood, United States
Latest news
No headlines yet.
